Molecular-biological diagnostics in bone and soft tissue tumours;Moleculair-biologische diagnostiek bij tumoren van het steun- en bewegingsapparaat

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 52, 1997, Pages 2557-2562

  Bovee J V M G ^a   Hogendoorn, P C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE TUMOR; CHROMOSOME TRANSLOCATION; DIAGNOSTIC TEST; GENE MUTATION; MOLECULAR CLONING; NOTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE TUMOR;

BONE DISEASES; DIAGNOSIS, DIFFERENTIAL; HETEROZYGOTE; HUMANS; KARYOTYPING; ONCOGENES; POLYMERASE CHAIN REACTION; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0031588427     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (28)

1. Sandberg M, Bridge JA. The cytogenetics of bone and soft tissue tumors. Austin: Landes, 1994.
2. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, et al. The Ewing family of tumors. N Engl J Med 1994;331:294-9.
3. Downing JR, Head DR, Parham DM, Douglass EC, Hulshof MG, Link MP, et al. Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol 1993;143: 1294-300.
4. Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 1996;78:10-6.
5. MIC2. Am J Pathol 1991;139:317-25.
6. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT. A second Ewing's sarcoma translocation, 1(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 1994;6:146-51.
7. Scrable H, Witte D, Shimada H, Seemayer T, Sheng WW, Soukup S, et al. Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer 1989;1:23-35.
8. Douglass EC, Valentine M, Etcubanas E, Parham D, Webber BL, Houghton PJ, et al. A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 1987;45:148-55.
9. Shapiro DN, Sublett JE, Li B, Downing JR, Naeve CW. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 1993;53.5108-12.
10. Dias P, Kumar P, Marsden HB, Gattamaneni HR, Heighway J, Kumar S. N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS. Int J Cancer 1990;45:593-6.
11. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4.
12. Caron H, Sluis P van, Kraker J de, Bokkerink J, Egeler M, Laureys G, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996; 334:225-30.
13. Schleiermacher G, Peter M, Michon J, Zucker JM, Thomas G, Magdalenat H, et al. A multiplex PCR assay for routine evaluation of deletion of the short arm of chromosome 1 in neuroblastoma. Eur J Cancer 1995;31A:535-8.
14. Turc-Carel C, Dal Cin P, Limon J, Rao U, Li FP, Corson JM, et al. Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci USA 1987,84:1981-5.
15. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18) (p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994;7:502-8.
16. Shipley J, Crew J, Birdsall S, Gill S, Clark J, Fisher C, et al. Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. Am J Pathol 1996,148:559-67.
17. Mertens F, Rydholm A, Bauer HF, Limon J, Nedoszytko B, Szadowska A, et al. Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer 1995;61:793-8.
18. Jhanwar SC, Chen Q, Li FP, Brennan MF, Woodruff JM. Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Cancer Genet Cytogenet 1994;78:138-44.
19. Skuse GR, Kosciolek BA, Rowley PT. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer 1989;1: 36-41.
20. Mandahl N, Heim S, Willen H, Rydholm A, Eneroth M, Nilbert M, et al. Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chromosomes Cancer 1989;1:9-14.
21. Rydholm A, Mandahl N, Heim S, Kreicbergs A, Willen H, Mitelman F. Malignant fibrous histiocytomas with a 19p+ marker chromosome have increased relapse rate. Genes Chromosomes Cancer 1990;2: 296-9.
22. Bridge JA, Borek DA, Neff JR, Huntrakoon M. Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis. Am J Clin Pathol 1990;93:26-31.
23. Fletcher JA. Translocation (12;22)(q13-14;q12) is a nonrandom aberration in soft-tissue clear-cell sarcoma. Genes Chromosomes Cancer 1992;5:184
24. Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 1993;4:341-5.
25. Fletcher JA, Kozakewich HP, Hoffer FA, Lage JM, Weidner N, Tepper R, et al. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med 1991;324:436-42.
26. Molenaar WM, DeJong B, Buist J, Idenburg VJ, Seruca R, Vos AM, et al. Chromosomal analysis and the classification of soft tissue sarcomas. Lab Invest 1989;60:266-74.
27. Sozzi G, Minoletti F, Miozzo M, Sard L, Musso K, Azzarelli A, et al. Relevance of cytogenetic and fluorescent in situ hybridization analyses in the clinical assessment of soft tissue sarcoma. Hum Pathol 1997;28:134-42.
28. Barr FG, Chatten J, D'Cruz CM, Wilson AE, Nauta LE, Nycum LM, et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 1995;273 553-7.